Evidence map›Paper›PMID 36288707›Full record

ArticleCell reports2022

GM-CSF

Srinivasu Mudalagiriyappa, Jaishree Sharma, Miranda D Vieson, Som Gowda Nanjappa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Fungal immunization potentiates CD4Frontiers in immunology · 2025
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Srinivasu MudalagiriyappaDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Jaishree SharmaDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Miranda D ViesonVeterinary Diagnostic Laboratory, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Som Gowda NanjappaDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA. Electronic address: nanjappa@illinois.edu.
University of Illinois Urbana-Champaign · US

Funding

Immunity against fungal infectionsR01AI153522 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NANJAPPA, SOMASHEKARAPPA GOWDA · 2021 to 2025
$2.3M
Role of GM-CSF+IL-17+ CD8+ T Cells in Respiratory Fungal ImmunityR21AI119945 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI NANJAPPA, SOMASHEKARAPPA GOWDA · 2016 to 2017
$425k
NIAID NIH HHS R01 AI153522NIAID NIH HHS R21 AI119945
6 · The paper itself

Abstract

GM-CSF co-expressing T17 cells instigate pathologic inflammation during autoimmune disorders, but their function in immunity to infections is unclear. Here, we demonstrate the role of GM-CSF

Indexed as

PneumoniaVaccinesAnimalsCD8-Positive T-LymphocytesInterleukin-1Interleukin-23MiceMice, Inbred C57BLInterleukin-1Interleukin-23VaccinesCP: ImmunologyfungalGM-CSFGM-CSF(+) Tc17 cellsIL-1IL-17AIL-23immunitypathologyvaccine

Identifiers

PMID36288707
PMCPMC9641983
OpenAlexW4307497060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.